A phase IIa, double-blind, randomised, placebo-controlled, dose-finding study on the efficacy and tolerability of a 6-week treatment with ZED1227 capsules vs. placebo in subjects with well-controlled celiac disease undergoing gluten challenge
Laufzeit: 01.01.2020 - 31.12.2020
imported
Kurzfassung
Dr. Falk Pharma (Principal Investigator)